Cargando…
Molecular markers as therapeutic targets in lung cancer
Lung cancer is responsible for 29% of cancer deaths in the United States and has very low 5-year survival rates of approximately 11% in men and 15% in women. Although the early diagnosis of lung cancer may increase the survival rate with adequate treatment, advanced lung cancers are often metastasiz...
Autores principales: | Tseng, Hsin-Hui, He, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845617/ https://www.ncbi.nlm.nih.gov/pubmed/23369726 http://dx.doi.org/10.5732/cjc.013.10011 |
Ejemplares similares
-
Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer?
por: Morelli, Maria Beatrice, et al.
Publicado: (2022) -
Molecular Imaging in Targeted Therapeutics
por: Wang, Yuebing, et al.
Publicado: (2018) -
Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics
por: Hsieh, Pei-Ling, et al.
Publicado: (2022) -
Immunobiology of Solid Cancers: Cellular and Molecular Pathways as Potential Diagnostic and Therapeutic Targets
por: Ruscito, Ilary, et al.
Publicado: (2018) -
Molecular Markers in the Diagnosis and Treatment of Cancer
por: Gokden, Murat, et al.
Publicado: (2015)